Clinical Trial

Non-invasive Neurostimulation as a Tool for Diagnostics and Management for Neurodegenerative Diseases

Recruiting
View on ClinicalTrials.gov →
Summary
Double blinded, sham-controlled, randomized trial on repeated transcranial alternating current brain stimulation (tACS) in neurodegenerative diseases. The investigators will evaluate whether a 4-times daily repeated stimulation with gamma tACS on the posterior parietal cortex can improve symptoms in patients with neurodegenerative diseases, including dementia with Lewy Bodies, Alzheimer's disease, idiopathic normal pressure hydrocephalus and Frontotemporal dementia.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2022-04-11; most recent amendment 2025-08-26.
Status change: Not Yet Recruiting → Recruiting 2022-11-22
Trial Details
NCT Number NCT05326750
Lead Sponsor Kuopio University Hospital
Conditions Alzheimer Disease, Frontotemporal Dementia, Dementia With Lewy Bodies
Enrollment 200 participants
Start Date 2022-11-21
Primary Completion 2032-07 (estimated)
Study Completion 2032-07 (estimated)
Updated on ClinicalTrials.gov 2025-09-03